Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis
- PMID: 28970148
- PMCID: PMC5794571
- DOI: 10.1016/j.cgh.2017.09.041
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis
Abstract
Background & aims: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, affecting 75-100 million Americans. However, the disease burden may not be equally distributed among races or ethnicities. We conducted a systematic review and meta-analysis to characterize racial and ethnic disparities in NAFLD prevalence, severity, and prognosis.
Methods: We searched MEDLINE, EMBASE, and Cochrane databases through August 2016 for studies that reported NAFLD prevalence in population-based or high-risk cohorts, NAFLD severity including presence of nonalcoholic steatohepatitis (NASH) and significant fibrosis, and NAFLD prognosis including development of cirrhosis complications and mortality. Pooled relative risks, according to race and ethnicity, were calculated for each outcome using the DerSimonian and Laird method for a random-effects model.
Results: We identified 34 studies comprising 368,569 unique patients that characterized disparities in NAFLD prevalence, severity, or prognosis. NAFLD prevalence was highest in Hispanics, intermediate in Whites, and lowest in Blacks, although differences between groups were smaller in high-risk cohorts (range 47.6%-55.5%) than population-based cohorts (range, 13.0%-22.9%). Among patients with NAFLD, risk of NASH was higher in Hispanics (relative risk, 1.09; 95% CI, 0.98-1.21) and lower in Blacks (relative risk, 0.72; 95% CI, 0.60-0.87) than Whites. However, the proportion of patients with significant fibrosis did not significantly differ among racial or ethnic groups. Data were limited and discordant on racial or ethnic disparities in outcomes of patients with NAFLD.
Conclusions: In a systematic review and meta-analysis, we found significant racial and ethnic disparities in NAFLD prevalence and severity in the United States, with the highest burden in Hispanics and lowest burden in Blacks. However, data are discordant on racial or ethnic differences in outcomes of patients with NAFLD.
Keywords: Disparities; Ethnicity; Fatty Liver Disease; Nonalcoholic Steatohepatitis.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2021 Jan;19(1):61-71.e15. doi: 10.1016/j.cgh.2020.04.067. Epub 2020 Apr 30. Clin Gastroenterol Hepatol. 2021. PMID: 32360810 Free PMC article. Review.
-
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Gastroenterology. 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4. Gastroenterology. 2020. PMID: 32027911
-
Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.Am J Gastroenterol. 2017 Apr;112(4):581-587. doi: 10.1038/ajg.2017.5. Epub 2017 Feb 14. Am J Gastroenterol. 2017. PMID: 28195177
-
Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):114-122. doi: 10.1016/j.numecd.2019.09.004. Epub 2019 Sep 10. Nutr Metab Cardiovasc Dis. 2020. PMID: 31761548 Free PMC article.
-
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484. Transplantation. 2019. PMID: 30335697 Review.
Cited by
-
Fighting liver fat.Endocr Connect. 2020 Jul;9(7):R173-R186. doi: 10.1530/EC-20-0174. Endocr Connect. 2020. PMID: 32621584 Free PMC article. Review.
-
Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular Carcinoma.Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):353-358. doi: 10.1002/cld.1057. eCollection 2021 May. Clin Liver Dis (Hoboken). 2021. PMID: 34136141 Free PMC article. Review. No abstract available.
-
Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.Cell Mol Life Sci. 2020 Jun;77(11):2079-2090. doi: 10.1007/s00018-019-03390-0. Cell Mol Life Sci. 2020. PMID: 31760464 Free PMC article. Review.
-
Prevalence of non-alcoholic fatty liver disease in the Russian Ural Eye and Medical Study and the Ural Very Old Study.Sci Rep. 2022 May 12;12(1):7842. doi: 10.1038/s41598-022-12004-y. Sci Rep. 2022. PMID: 35551494 Free PMC article.
-
Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease.Hepatology. 2022 Apr;75(4):955-967. doi: 10.1002/hep.32197. Epub 2021 Dec 13. Hepatology. 2022. PMID: 34633706 Free PMC article.
References
-
- Rinella ME. Nonalcoholic fatty liver disease: a systematic review. Jama. 2015;313:2263–73. - PubMed
-
- Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–85. - PubMed
-
- Browning JD, Kumar KS, Saboorian MH, et al. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol. 2004;99:292–8. - PubMed
-
- Caldwell SH, Harris DM, Patrie JT, et al. Is NASH underdiagnosed among African Americans? The American journal of gastroenterology. 2002;97:1496–500. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical